Article info

Download PDFPDF

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib

Authors

  1. Correspondence to Professor Bernard Combe, Department of Rheumatology, CHU Montpellier and University of Montpellier, Hôpital Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier cedex 5, France; b-combe{at}chu-montpellier.fr
View Full Text

Citation

Combe B, Balsa A, Sarzi-Puttini P, et al
Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib

Publication history

  • Received August 10, 2018
  • Revised February 7, 2019
  • Accepted February 8, 2019
  • First published March 6, 2019.
Online issue publication 
July 11, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.